Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Am Heart J ; 168(6): 884-90, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25458652

ABSTRACT

BACKGROUND: Borderline electrocardiograms represent a challenge in ST-segment elevation myocardial infarction (STEMI) management and are associated with inappropriate discharges and delays to intervention. OBJECTIVES: To assess angiographic characteristics and outcomes of patients presenting with subtle ST-elevation (STE) myocardial infarction. METHODS: A total of 504 consecutive patients with suspected STEMI treated by systematic primary percutaneous coronary intervention were prospectively included. Subtle STE was defined as a maximal preinterventional STE of 0.1 to 1 mm. Angiograms were interpreted by investigators unaware of the electrocardiographic data. RESULTS: The proportion of patients with subtle STE was 18.3%, 86% of them presented with Thrombolysis In Myocardial Infarction flow grade 0/1 and 91% underwent percutaneous coronary intervention. Despite having smaller infarcts, subtle STE patients associated more frequent multivessel disease (57% vs 44%, P = .02) and larger delays to reperfusion. During a follow-up of 19.0 ± 4.9 months, the rates of death or reinfarction were similar among groups (10.0% vs 12.6%, P = .467). Subtle STE was not associated with better outcomes neither in univariate nor after adjustment in a multivariate analysis (adjusted hazard ratio 0.79, 95% CI 0.37-1.69, P = .546). CONCLUSIONS: Subtle STEMI is frequent in clinical practice and is usually associated with acute total coronary occlusion. Therefore, it should be diagnosed and treated in the same expeditiously manner as marked STEMI.


Subject(s)
Coronary Angiography/methods , Coronary Disease , Coronary Vessels , Myocardial Infarction , Percutaneous Coronary Intervention , Aged , Coronary Disease/complications , Coronary Disease/pathology , Coronary Disease/physiopathology , Coronary Disease/therapy , Coronary Vessels/diagnostic imaging , Coronary Vessels/pathology , Disease Management , Electrocardiography/methods , Female , Humans , Incidence , Male , Middle Aged , Myocardial Infarction/diagnosis , Myocardial Infarction/etiology , Myocardial Infarction/mortality , Myocardial Infarction/therapy , Outcome Assessment, Health Care , Percutaneous Coronary Intervention/methods , Percutaneous Coronary Intervention/statistics & numerical data , Prognosis , Severity of Illness Index , Spain/epidemiology , Survival Analysis , Time-to-Treatment/statistics & numerical data
2.
Med Clin (Barc) ; 131(13): 481-6, 2008 Oct 18.
Article in Spanish | MEDLINE | ID: mdl-19007575

ABSTRACT

BACKGROUND AND OBJECTIVE: Primary angioplasty is an effective method to achieve myocardial reperfusion in ST-elevated myocardial infarction (MI). The objective of this study was to determine the independent factors that could predict mortality in MI patients treated with primary angioplasty and to analyze the prognostic value of tissue reperfusion parameters in those patients. PATIENTS AND METHOD: A prospective observational study was performed in 380 consecutive patients with ST-elevated MI treated with primary angioplasty at a single hospital. RESULTS: Early mortality was 8.9%. Upon univariate analysis, the following variables were associated with significantly higher mortality: age, ejection fraction (EF), multivascular disease, anterior location of MI, lack of resolution of ST segment, flow 0-1 of TIMI, grade 0-1 of blush index and delay time above 4 hours. Multivariate analysis yielded the following independent variables as predictors of mortality: age, degree of heart failure (Killip index) and degree of myocardial perfusion (blush index). CONCLUSIONS: The independent predictive factors of mortality in patients with ST-elevated MI and treated with primary angioplasty are: age, degree of heart failure (Killip index) and degree of myocardial reperfusion (blush index). The resolution of ST segment and blush index represent additional prognostic variables in patients with good epicardial reperfusion.


Subject(s)
Angioplasty, Balloon, Coronary/mortality , Myocardial Infarction/mortality , Analysis of Variance , Female , Heart Failure/complications , Hospital Mortality , Humans , Male , Middle Aged , Myocardial Infarction/therapy , Myocardial Reperfusion , Prognosis , Prospective Studies , Stents
3.
Coron Artery Dis ; 27(3): 169-75, 2016 May.
Article in English | MEDLINE | ID: mdl-26513293

ABSTRACT

OBJECTIVE: Angiographic thrombus burden (TB) can be assessed early and enable a decision on intervention. The aim of this study was to analyze its effect on the incidence of cardiac events after a primary percutaneous coronary intervention. PATIENTS AND METHODS: We carried out a prospective study of 480 consecutive ST-segment elevation myocardial infarction patients treated by systematic primary percutaneous coronary intervention. Large TB was defined as thrombus length at least 2 vessel diameters or as solid thrombus obtained through catheter aspiration. The primary outcome measure was a composite of death, reinfarction, or target vessel revascularization. RESULTS: A total of 205 (47%) patients fulfilled the criteria for large TB. These patients were more frequently treated with abciximab (62.0 vs. 35.8%, P<0.001), showed more angiographic complications (26.6 vs. 13.7%, P=0.001), and had larger infarcts (peak troponin I, 74 vs. 50 ng/ml, P=0.015). During a follow-up of 19 ± 5 months, the rates of primary outcome were similar between groups of small and large TB (16.2 vs. 12.8%, hazard ratio: 0.88, 95% confidence interval: 0.46-1.67, P=0.691). There were no differences in the rates of definite stent thrombosis (0.5 vs. 2.2%, P=0.190). CONCLUSION: Large TB is associated with larger infarct size, but not with worse mid-term outcomes. Selective use of adjuvant therapies according to TB may be an effective approach to reduce thrombotic complications.


Subject(s)
Coronary Thrombosis/therapy , Percutaneous Coronary Intervention , ST Elevation Myocardial Infarction/therapy , Abciximab , Aged , Antibodies, Monoclonal/therapeutic use , Coronary Angiography , Coronary Thrombosis/complications , Coronary Thrombosis/diagnostic imaging , Coronary Thrombosis/mortality , Female , Humans , Immunoglobulin Fab Fragments/therapeutic use , Kaplan-Meier Estimate , Male , Middle Aged , Percutaneous Coronary Intervention/adverse effects , Percutaneous Coronary Intervention/instrumentation , Percutaneous Coronary Intervention/mortality , Platelet Aggregation Inhibitors/therapeutic use , Proportional Hazards Models , Prospective Studies , Recurrence , Registries , Risk Factors , ST Elevation Myocardial Infarction/diagnostic imaging , ST Elevation Myocardial Infarction/etiology , ST Elevation Myocardial Infarction/mortality , Severity of Illness Index , Stents , Time Factors , Treatment Outcome
4.
Rev Esp Cardiol ; 58(12): 1479-81, 2005 Dec.
Article in Spanish | MEDLINE | ID: mdl-16371210

ABSTRACT

Obesity increases significantly the rate of postsurgical complications and mortality in patients undergoing major surgery. We present the case of a morbidly obese 65-year-old female with severe aortic stenosis and left main coronary artery disease who underwent successful aortic valvuloplasty and angioplasty, with placement of a stent in the left main coronary artery. After undergoing bariatric surgery and losing 30% of her body weight, the patient was accepted for cardiac surgery to replace the aortic valve and to bypass the left anterior descending coronary artery using the mammary artery. There were no surgical complications.


Subject(s)
Angioplasty, Balloon, Coronary , Aortic Valve Stenosis/therapy , Aged , Aortic Valve Stenosis/complications , Cardiac Surgical Procedures/methods , Coronary Angiography , Coronary Disease/complications , Coronary Disease/surgery , Coronary Vessels/surgery , Female , Humans , Obesity/complications
SELECTION OF CITATIONS
SEARCH DETAIL